Insights Into Metastatic Colorectal Cancer (mCRC) – Midwest

Analysis on treatment approaches, shared decision-making, and emerging options for refractory mCRC from community oncologists from the Midwest region.

January 26, 2026
Purchase Report

MODERATOR

Tanios Bekaii-Saab, MD, FACP, FASCO

Mayo Clinic Cancer Center, Scottsdale, AZ, USA

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • Examine how clinical factors, patient characteristics, and current practices drive third-line-and-later treatment decisions in microsatellite-stable mCRC
  • Assess community oncologists’ perceptions of real-world experiences with available later-line therapeutic options
  • Analyze treatment strategies, supporting evidence, and ARS-derived insights in the refractory microsatellite-stable setting to inform future therapeutics

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collection was conducted through the utilization of an audience response system and facilitated moderated discussion
  • The attendees included 9 community oncologists from the Midwest region of the United States

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.